Open AccessPAPILLARY THYROID CARCINOMA CONCOMITANT WITH THYROTOXICOSIS
Author(s) -
DAVIT KALMAKHELIDZE,
ZURAB ZAALISHVILI,
ASHWIN ACHUTHAPRASAD,
TEKLE DARTSIMELIA,
LEVAN KALMAKHELIDZE
Publication year - 2022
Publication title -
ek'sperimentuli da klinikuri medic'ina
Language(s) - English
Resource type - Journals
ISSN - 1512-0392
DOI - 10.52340/jecm.2022.02.07
Subject(s) - medicine , concomitant , thyroid carcinoma , histopathology , malignancy , thyroid cancer , thyroid , thyroidectomy , incidence (geometry) , lymph node , goiter , radiology , pathology , physics , optics
Contrary to the preconceived belief, the occurrence of hyperthyroidism in patients with thyroid cancer is gaining in incidence. The research team retrospectively analysed studies such as serum TSH and T4 levels, thyroid ultrasound results, and the histopathology reports of 9 patients (age range 20-67) from Mardaleishvili Medical Center. All patients were diagnosed with PTC. 7 patients had microcarcinoma (mean 6.1mm) and 2 – large tumors (mean 14mm). Graves’ disease was found in 5 patients, toxic nodular goiter in 3 and one patient’s record was lacking comorbid disease information. One patient had confirmed lymph node involvement. All patients underwent total thyroidectomy. Overall, all 9 patients with hyperthyroidism were subsequently diagnosed with thyroid cancer. Management of such patients has questioned the validity of the guidelines published by the ATA and emphasizes the fact that malignancy should not be excluded in patients with thyrotoxicosis.